MARKET

ADPT

ADPT

Adaptive Biotechnologies
NASDAQ
5.26
-0.05
-0.94%
Closed 16:27 11/04 EST
OPEN
5.30
PREV CLOSE
5.31
HIGH
5.53
LOW
5.16
VOLUME
1.16M
TURNOVER
0
52 WEEK HIGH
5.80
52 WEEK LOW
2.280
MARKET CAP
775.70M
P/E (TTM)
-3.5873
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ADPT last week (1028-1101)?
Weekly Report · 1d ago
Does Adaptive Biotechnologies (NASDAQ:ADPT) Have A Healthy Balance Sheet?
Simply Wall St · 4d ago
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Benzinga · 4d ago
Weekly Report: what happened at ADPT last week (1021-1025)?
Weekly Report · 10/28 09:24
Weekly Report: what happened at ADPT last week (1014-1018)?
Weekly Report · 10/21 09:24
Maintaining Hold on Adaptive Biotechnologies Amidst Gradual Market Adoption and Competitive Challenges
TipRanks · 10/15 06:16
Weekly Report: what happened at ADPT last week (1007-1011)?
Weekly Report · 10/14 09:29
Weekly Report: what happened at ADPT last week (0930-1004)?
Weekly Report · 10/07 09:27
More
About ADPT
Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company. The Company is focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its immune medicine platform applies its proprietary technologies to read the diverse genetic code of a patient’s immune system and understand precisely how the immune system detects and treats disease in that patient. It has business around two main areas: clinical assessment of minimal residual disease (MRD) in lymphoid malignancies and immune medicine (IM)-driven drug discovery and development. The MRD business focuses on the use of its highly sensitive, next-generation sequencing (NGS) assay to measure MRD in patients with hematologic malignancies. It comprises its clonoSEQ clinical diagnostic test, offered to clinicians, and its clonoSEQ assay, offered to biopharmaceutical partners, to advance drug development efforts (MRD Pharma).

Webull offers Adaptive Biotechnologies Corp stock information, including NASDAQ: ADPT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADPT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ADPT stock methods without spending real money on the virtual paper trading platform.